Sarclisa 100 mg/5 mL (20 mg/mL) injection Images
Generic Name: isatuximab
This medication has been identified as Sarclisa 100 mg/5 mL (20 mg/mL) injection. It is supplied by Sanofi.
Sarclisa is used in the treatment of Multiple Myeloma and belongs to the drug class CD38 monoclonal antibodies. Sarclisa 100 mg/5 mL (20 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Sarclisa
- Generic Name
- isatuximab
- Strength
- 100 mg/5 mL (20 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- CD38 monoclonal antibodies
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sanofi
- National Drug Code (NDC)
- 00024-0654
More about Sarclisa (isatuximab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CD38 monoclonal antibodies
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.